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An increasing proportion of cases notified for
tuberculosis in industrialised countries are seen
among foreign-born people and in particular im-
migrants from countries with a high incidence of
tuberculosis [1]. Therefore, screening for tubercu-
losis by chest X-ray is generally recommended in
this population to prevent transmission of the dis-
ease within the immigrant group and to the local
population [2], although the screening yield is usu-
ally low. Screening for latent tuberculosis infection
by tuberculin skin test (TST) detects a higher pro-
portion of persons who could benefit from pre-
ventive treatment [3] but is more controversial be-
cause it involves screening of symptom-free indi-
viduals and prescription of preventive treatment to
many in order to prevent the future development
of the disease in a few. Furthermore, the main test
used for detection of tuberculosis infection is of
questionable validity and its predictive value is un-
satisfactory. In spite of these limitations, the size of
the TST correlates with the risk of TB among im-
migrants [4, 5] and the benefit and cost-effective-
ness of treating latent tuberculosis infection have
been demonstrated in several studies [6–8], al-
though it may decrease with age [9]. Therefore,
screening for LTBI is considered cost-effective in
populations with a high incidence of tuberculosis,
provided treatment is offered to the individuals at
highest risk of reactivation [10]. 
Most persons seeking asylum in Switzerland
Aim of the study: To evaluate the compliance of
doctors and patients with the current recommen-
dations for screening and preventive treatment of
immigrants with a positive tuberculin skin test
(TST) suggestive of latent tuberculosis infection
(LTBI).
Methods: Retrospective cohort study of all asy-
lum seekers entering Switzerland between 1 Janu-
ary 1993 and 31 December 1993 and assigned to
the cantons of Aargau, Fribourg, Geneva, Neuchâ-
tel, Valais and Vaud, who underwent a TST at the
border. The medical documents of all individuals
with a TST size suggestive of LTBI (010 mm in
children <15 years, 018 mm in young adults aged
15–25 years) were reviewed for final diagnosis,
therapeutic decision, compliance with treatment if
prescribed, and notification for tuberculosis within
the next 3 years.
Results: Among 2515 asylum seekers, 172 had
a positive TST suggestive of LTBI. The docu-
ments of 93 persons were available. The final
diagnosis was LTBI in 71 cases, possible tubercu-
losis in 10 cases, an effect of BCG immunisation in
10 cases, and other diagnoses in 2 cases. Among 82
individuals with normal chest X-ray or no radio-
logical examination, only 37 (46%) received a pre-
ventive treatment and one a full course of anti-
tuberculosis drugs. Among 11 persons with an
abnormal chest X-ray, 2 received a full course of
antituberculosis drugs, 7 a preventive therapy and
2 had no treatment prescribed. Among the 44 sub-
jects in whom a preventive treatment was pre-
scribed, 30 adhered to the treatment regimen. One
case (without prescribed treatment) was notified
for tuberculosis two years after entry.
Conclusions: Compliance of doctors and pa-
tients with current recommendations for examina-
tion and treatment of immigrants with a TST sug-
gestive of LTBI is unsatisfactory. New guidelines
are needed to provide a clearer definition of the in-
dications and explain the benefits of treating LTBI.
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Introduction
come from countries where the incidence of tu-
berculosis is higher than in western Europe. Some
have a positive TST resulting from prior infection
by M. tuberculosis. Assuming that the risk of further
development of tuberculosis is related to the size
of the test [11], the time elapsed since infection
[12], the subject’s age [12] and immunological sta-
tus [13], tuberculin testing for immigrants from
high-incidence countries and preventive treat-
ment (or treatment of latent tuberculosis infection)
for individuals at risk of reactivation have been rec-
ommended [2]. These recommendations have re-
cently been reiterated by the Centers for Disease
Control and the American Thoracic Society [7]. 
Since 1992, all asylum seekers (AS) entering
Switzerland have been required to undergo
screening at the border, including a TST and a
miniature chest X-ray (except for children and
pregnant women) in special screening centres run
by the Swiss Office for Refugees [14]. All AS with
a positive TST suggestive of tuberculosis infec-
tion, and all carriers of a radiological abnormality,
are notified for further examination to the health
authorities of the cantons (county) to which they
are assigned after entry. According to the current
recommendations, children under 15 years with a
TST 010 mm and young adults aged 15–25 years
with a TST 018 mm should receive preventive
treatment after ruling out active tuberculosis or a
full course of therapy if active disease is proven or
suspected [15]. 
In 1993, the incidence of tuberculosis in
Switzerland was 10.8/100,000 (8.4/100,000
among Swiss citizens and 21.1/100,000 among for-
eign-born residents, excluding asylum seekers for
whom no incidence can be calculated owing to the
changing numbers of this population).
The aim of this study was to assess retrospec-
tively, in a sample of asylum seekers entered dur-
ing the year following implementation of the new
screening procedure at the border, whether the
guidelines for the treatment of persons with a po-
tential tuberculosis infection or untreated tuber-
culosis were followed by the examining doctors
and the degree of compliance with the prescribed
treatment.
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Method
From the database of the Border Health Control we
selected all asylum seekers arrived between 1 January and
31 December 1993 who were found to have a positive TST
possibly indicative of LTBI and in whom preventive treat-
ment should have been considered [15]. A written request
was then sent to the local health authorities of 7 cantons,
representing one-third of the country’s population, asking
for permission to study the medical reports of these AS in
hospitals, outpatient clinics, or medical offices where the
first medical examination had been performed.
From the available medical reports in the cantons
where permission was given we collected information by
questionnaire to screening centres on the results of med-
ical and radiological examinations (if performed), the final
diagnosis (tuberculosis, tuberculosis infection or other di-
agnosis), the decision to treat, and compliance with treat-
ment if prescribed. The original medical records and the
X-rays were not checked. We also checked in the tuber-
culosis notification files of the Swiss Federal Office of
Public Health whether any of these AS had been notified
for tuberculosis during the 3 years following entry.
Results
In 1993, 21,664 asylum seekers were screened
in border centres of the Federal Office for
Refugees. A TST was performed and read in
17,546 subjects, of whom 9,328 were aged <26
years. Of these, 2,515 (27%) were assigned to the
6 cantons where we received permission to study
the medical files (Aargau, Fribourg, Geneva,
Neuchâtel, Valais and Vaud). In this group, 172 AS
satisfied the definition of possible LTBI. The local
health authorities of one canton declined to send
the information (on confidentiality grounds).
Complete medical documentation was available
for 93 AS (54%). For the remaining 79 cases the
information was unobtainable, either because the
AS never appeared for the scheduled visit or
because the information was no longer available.
Among the 93 AS with complete documenta-
tion, 72 also had a chest X-ray. 61 of them were
considered normal and 11 showed some radiolog-
ical abnormality (suggestive of tuberculosis or
not). 21 underwent no radiological examination
(18 children and 3 young adults). Three AS were
notified for tuberculosis shortly after entry (one
for extrapulmonary tuberculosis with a normal
chest X-ray and two for culture-negative pul-
monary tuberculosis with a radiological abnormal-
ity).
The diagnosis mentioned in the records of the
remaining 90 AS was LTBI in 71 (79%), tubercu-
losis in 7 (8%), and positive skin test reaction due
to prior BCG immunisation in 10 (11%). In 2 cases
no final diagnosis was mentioned. 
Among 82 AS with a normal chest X-ray or no
radiological examination at the border, 36 (46%)
received some form of preventive treatment (12 of
32 children and 24 of 50 young adults) and one a
full course of antituberculosis drugs. Among 11 AS
with a radiological abnormality, 2 were prescribed
a full course of tuberculosis treatment, 7 a preven-
tive treatment and 2 received no treatment (table).
Prescription of treatment varied between cantons
from 11% to 87%.
Of 44 AS in whom preventive treatment was
prescribed, 34 (77%) were regularly followed and
considered compliant, 7 (16%) defaulted and 3
(7%) missed the final appointment. No treatment
was modified or halted because of side effects or
intolerance.
One AS in this group was notified for tuber-
culosis to the SFOPH two years after entry into
Switzerland. The subject had had a positive TST
and a normal chest X-ray but no preventive treat-
ment was prescribed. Among AS in whom preven-
tive treatment was prescribed, no case was notified
for tuberculosis. 
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Discussion
Our study suggests that management of AS
with a positive TST does not comply with current
recommendations. Only 77% of AS with a possi-
ble LTBI underwent chest X-ray and treatment
was prescribed in 40% of children and 48% of
young adults with a positive TST and a normal
chest X-ray. On the other hand, preventive or cu-
rative treatment was prescribed in 9 out of 11 indi-
viduals (82%) with an abnormal chest X-ray.
In our study adherence to treatment, once pre-
scribed, was satisfactory (77%) and no intolerance
or side effects were reported. We assume that the
cases without preventive treatment were not of-
fered it and that treatment was not actively refused.
Although anecdotal, it is interesting to note that
one among 46 AS who did not receive preventive
treatment was later notified for tuberculosis, while
none of the 47 immigrants treated preventively
was notified within 3 years after entry.
Since a large proportion of cases of tuberculo-
sis notified in western countries are observed
among persons already known to have latent tu-
berculosis infection but left untreated, the pre-
scription of treatment for latent tuberculosis in-
fection could contribute to a decrease in incidence
in future years [16]. There is controversy about the
feasibility of carrying out so prolonged a treatment
in symptom-free recent immigrants. According to
one Swiss study, the treatment of latent tuberculo-
sis infection is unrealistic since compliance with
the treatment is unsatisfactory [17]. Another Swiss
study demonstrated that even recent immigrants
may be compliant with the prescribed treatment if
cared for in an appropriate environment [18]. The
same study observed a 4% rate of tuberculosis re-
activation within 4 years among infected subjects
not prescribed treatment or refusing it. A study
conducted in Italy demonstrated that the outcome
of preventive treatment among immigrants was as-
sociated with the quality of medical management
and was better in specialised services than in gen-
eral health services [19].
This study has several limitations. The size of
the population studied was small, representing
only 27% of the AS arriving in Switzerland in
1993. Selection of the cantons where the study was
performed was not random but based on the local
health authorities’ agreement to cooperate. We
cannot rule out that the results in other cantons
would have been even less satisfactory. Even so,
only 54% of the medical records of the immigrants
with a possible latent tuberculosis infection were
available 3 years after entry. Possible explanations
are the divided responsibilities at local level
between local authorities and doctors, the high
mobility of the AS population and the frequent
departure or disappearance of individuals facing
denial of refugee status.
Another limitation is the use of incorrect def-
initions of tuberculosis. We have to assume that the
four cases where a diagnosis of tuberculosis was
mentioned with normal chest X-ray, and in whom
only preventive treatment or no treatment at all
was prescribed, had tuberculosis infection and not
tuberculosis. We consider that there were only
three true cases of tuberculosis (one extrapul-
monary and two culture-negative pulmonary).
Moreover, in some children the diagnosis of tu-
berculosis infection was mentioned without per-
forming a chest X-ray. We assume that they were
Radiological examination at the border
Normal Any abnormality No X-ray Total
Children Young adults Children Young adults Children Young adults
<15 years 15 to 25 years <15 years 15 to 25 years <15 years  15 to 25 years
Preventive
treatment 5 23 1 6 8 1 44 (47%)
Full course of 
TB treatment 1 2 3 (3%)
No treatment 8 24 1 1 10 2 46 (50%)
Total 61 11 21 93
Table 1
Treatment prescribed
by age groups and
results of radiological
examination among
93 AS.
medically examined before prescription of preven-
tive treatment. No person was put on a full course
of tuberculosis treatment without a chest X-ray. 
In spite of these limitations, screening for la-
tent tuberculosis infection among a population at
high risk of infection and later development of tu-
berculosis may be justified if a positive TST is fol-
lowed by adequate examination and if the examin-
ers are aware of the benefit of preventive treat-
ment. In Switzerland the TST is performed at the
border and further investigations are performed by
another medical team in the cantons. A possible
strategy for improving this situation would be to
have TSTs performed by the physicians who will
be in charge of further treatment, if the test is
found to be positive. Furthermore, the tests should
be restricted to the age groups where the benefit
of preventive treatment appears to be greatest, i.e.
to children and young adults, and to persons who
would be willing to follow a treatment if indicated.
As very rightly mentioned in the recent recom-
mendations of the ATS and CDC, “intention to tu-
berculin test is intention to treat” [7]. We endorse
this statement and recommend that screening, if
performed, be followed by correct management of
the cases.
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